FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

Olanzapine (JAN/USAN/INN)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 35 USDMF, 25 CEP/COS, 15 JDMF, 16 EU WC, 13 KDMF, 20 NDC API, 44 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

68 Drugs in Development

68 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1525 FDF Dossiers, 223 FDA Orange Book, 944 Europe, 108 Canada, 55 Australia, 65 South Africa, 130 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 15MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG, TABLET, ORALLY DISINTEGRATING;ORAL - 20MG, TABLET, ORALLY DISINTEGRATING;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Rochem International Inc, 21 SPI Pharma, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 1 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 3 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 14 DKSH, 1 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 16 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 45 Direct Compression, 39 Thickeners and Stabilizers, 36 Solubilizers, 34 Granulation, 33 Disintegrants & Superdisintegrants, 29 Taste Masking, 25 Topical, 25 Controlled & Modified Release, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Parenteral, 18 Film Formers & Plasticizers, 13 Emulsifying Agents, 13 Co-Processed Excipients, 10 Rheology Modifiers, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

92 News #PharmaBuzz

92 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 198 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

20 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 4 US Exclusivities, 26 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
29/01/2026	TAPI Technology & API Services	Israel	Teva API India Private Ltd	15894-0006	Olanzapine	2019-07-15	2026-12-31	BULK INGREDIENT	POWDER (100kg/100kg)
29/01/2026	Apotex Inc	Canada	Apotex Inc.	49867-0073	OLANZAPINE	2022-07-28	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Olanzapine (JAN/USAN/INN)

Olanzapine (JAN/USAN/INN)

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers

35 USDMF

25 CEP/COS

15 JDMF

16 EU WC

13 KDMF

20 NDC API

44 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

68 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1525 FDF Dossiers

223 FDA Orange Book

944 Europe

108 Canada

55 Australia

65 South Africa

130 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 15MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 7.5MG

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

TABLET, ORALLY DISINTEGRATING;ORAL - 15MG

TABLET, ORALLY DISINTEGRATING;ORAL - 20MG

TABLET, ORALLY DISINTEGRATING;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Rochem International Inc

21 SPI Pharma

1 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 Capital Farma

1 Kirsch Pharma

1 Panvo Organics

4 ACG Worldwide

9 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

30 BASF

1 Bioplus Life Sciences

3 Clariant

11 Corel Pharma Chem

5 DFE Pharma

14 DKSH

1 Doshion Polyscience

1 Esteem Industries

3 Finar

12 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq